AGIO
Agios Pharmaceuticals, Inc.
35.00$
+3.0%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -839.7% | – | – | – | – | – | – | – | – | |
| – | +144.5% | +70.8% | +12.7% | +11.5% | +12.8% | +132.1% | -50.8% | -7.3% | -22.7% | -14.6% | -8.4% | |
| – | +177.8% | +31.7% | +13.6% | +53.4% | -1.3% | -14.9% | -13.1% | -7.9% | -9.2% | -4.3% | +22.7% | |
| – | +165.7% | +31.5% | +13.7% | +53.4% | +0.1% | +2.3% | -152.9% | – | – | – | – | |
| – | – | +3,741.5% | -113.2% | – | – | – | -1,973.9% | – | – | – | – | |
| – | +809.9% | -50.8% | -53.3% | +51.0% | +74.2% | +15.9% | -59.3% | -15.0% | -79.5% | +68.7% | +156.1% | |
| – | – | -193.0% | -51.5% | +372.9% | – | -17.2% | +1,548.6% | -80.5% | -1.5% | +51.7% | +3.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -98.1% | +2,564.0% | +67.9% | +91.5% | -46.9% | -96.1% | -7,191.0% | – | -100.0% | – | – | |
| – | – | – | +0.0% | +0.0% | +0.0% | +197.3% | +72.0% | -42.7% | -100.0% | – | – | |
| – | -98.1% | +2,564.0% | +67.9% | +91.5% | -47.0% | -9.7% | -392.8% | – | +131.2% | +165.8% | -39.9% | |
| – | – | +54.1% | -165.2% | – | – | +345.9% | +62.8% | -184.4% | – | – | – | |
| – | – | – | -1,111.8% | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.